Press

Unlimited Sciences Announces Groundbreaking New Study to Observe Ayahuasca’s Effects on Trauma

Aug 2 • 4 min read

Unlimited Sciences, a psychedelic research nonprofit, today announces a seminal new observation research study that will measure the potential healing effects of ayahuasca on individuals with past experiences of trauma. The study, beginning this summer, will engage mostly female immigrants and refugees seeking remedial therapy through the powerful psychoactive brew, which has been identified as…

Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results

Aug 1 • 7 min read

Braxia Scientific Corp. (CSE: BRAX | OTC: BRAXF | FWB: 4960), a medical research company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, today announced the filing of its audited financial statements and management discussion and analysis for the year ended March 31, 2022. Complete financial statements along with related management…

Delic Completes Offering of Debentures

Aug 1 • 3 min read

Delic Holdings Corp (CSE: DELC | OTCQB: DELCF | FRA: 6X0), a leader in new medicines and treatments for a modern world, is pleased to announce that it completed the sale of 1,240 units at a price of $1,000 per Unit for aggregate gross proceeds of $1,240,000, on July 27, 2022. Each Unit consists of one 4.0% senior secured, $1,064 ‎principal…

Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement

Jul 28 • 11 min read

Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL | NASDAQ: IXHL), is pleased to provide its quarterly activities report and appendix 4C for the period ended 30 June 2022. Incannex is undertaking a multitude of U.S. Food and Drug Administration programs for cannabinoid pharmaceutical products and psychedelic medicine therapies administered by health professionals. Cannabinoid IHL-42X:…

Hemplucid Becomes First Startup to Provide Psychedelic Therapy as Employee Healthcare Benefit

Jul 28 • 3 min read

HempLucid, a leading provider of plant-based wellness supplements, is the first startup to offer medically supervised Ketamine-Assisted Therapy (KAP) as an employee benefit. Ketamine is a general anesthetic, first used on the battlefields of Vietnam because it did not slow the heartrate like other anesthetics. Today, ketamine is used by first responders to calm people trying to…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441